Skip to main content

Nevro Corp(NVRO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides First Quarter and Complete Full-Year 2023 Guidance

PR Newswire - Thu Feb 16, 2023

REDWOOD CITY, Calif., Feb. 16, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced its fourth quarter and full-year 2022 financial results.  The company also provided first quarter and complete full-year 2023 guidance.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

opinion
This Canadian aerospace stock deserves a place on your watch list
Robert Tattersall